These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38356200)

  • 1. Keratinocytes in the pathogenesis, phenotypic switch, and relapse of psoriasis.
    Wang X; Lai Y
    Eur J Immunol; 2024 May; 54(5):e2250279. PubMed ID: 38356200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keratinocyte: A trigger or an executor of psoriasis?
    Ni X; Lai Y
    J Leukoc Biol; 2020 Aug; 108(2):485-491. PubMed ID: 32170886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular scars and local crosstalk in relapsing psoriasis: an example of a skin sticking disease.
    Gallais Sérézal I; Cheuk S; Martini E; Eidsmo L
    Scand J Immunol; 2020 Nov; 92(5):e12953. PubMed ID: 32757303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interplay between keratinocytes and immune cells--recent insights into psoriasis pathogenesis.
    Tonel G; Conrad C
    Int J Biochem Cell Biol; 2009 May; 41(5):963-8. PubMed ID: 19027868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psoriasis: Keratinocytes or Immune Cells - Which Is the Trigger?
    Benhadou F; Mintoff D; Del Marmol V
    Dermatology; 2019; 235(2):91-100. PubMed ID: 30566935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunopathogenesis of psoriasis.
    Sanchez AP
    An Bras Dermatol; 2010; 85(5):747-9. PubMed ID: 21152809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-7 downregulation in lesional keratinocytes contributes to enhanced IL-17A signaling and skin pathology in psoriasis.
    Chen HL; Lo CH; Huang CC; Lu MP; Hu PY; Chen CS; Chueh DY; Chen P; Lin TN; Lo YH; Hsiao YP; Hsu DK; Liu FT
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33055419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse models of psoriasis and their relevance.
    Nakajima K; Sano S
    J Dermatol; 2018 Mar; 45(3):252-263. PubMed ID: 29226571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of CD1d by keratinocytes in psoriasis and CD1d-dependent IFN-gamma production by NK-T cells.
    Bonish B; Jullien D; Dutronc Y; Huang BB; Modlin R; Spada FM; Porcelli SA; Nickoloff BJ
    J Immunol; 2000 Oct; 165(7):4076-85. PubMed ID: 11034419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resident T Cells in Resolved Psoriasis Steer Tissue Responses that Stratify Clinical Outcome.
    Gallais Sérézal I; Classon C; Cheuk S; Barrientos-Somarribas M; Wadman E; Martini E; Chang D; Xu Landén N; Ehrström M; Nylén S; Eidsmo L
    J Invest Dermatol; 2018 Aug; 138(8):1754-1763. PubMed ID: 29510191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Keratinocytes regain momentum as instigators of cutaneous inflammation.
    Nickoloff BJ
    Trends Mol Med; 2006 Mar; 12(3):102-6. PubMed ID: 16443394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cutting edge overview: psoriatic disease.
    Raychaudhuri SP
    Clin Rev Allergy Immunol; 2013 Apr; 44(2):109-13. PubMed ID: 22359072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stat3 activation in epidermal keratinocytes induces Langerhans cell activation to form an essential circuit for psoriasis via IL-23 production.
    Nakajima K; Kataoka S; Sato K; Takaishi M; Yamamoto M; Nakajima H; Sano S
    J Dermatol Sci; 2019 Feb; 93(2):82-91. PubMed ID: 30514663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type1 Interferons Potential Initiating Factors Linking Skin Wounds With Psoriasis Pathogenesis.
    Zhang LJ
    Front Immunol; 2019; 10():1440. PubMed ID: 31293591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brodalumab Seems to Recover Its Therapeutic Efficacy After a Relatively Short "Washout" Period with Anti-TNF Agents: A Successful Pattern for Double-switch Therapy.
    Tampouratzi E; Sfaelos K; Talaiporou K; Douvali Τ; Katsantonis J
    Acta Dermatovenerol Croat; 2023 Aug; 31(1):48-50. PubMed ID: 37843093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin innate immune system in psoriasis: friend or foe?
    Nickoloff BJ
    J Clin Invest; 1999 Nov; 104(9):1161-4. PubMed ID: 10545511
    [No Abstract]   [Full Text] [Related]  

  • 17. Interleukin 17 Promotes Expression of Alarmins S100A8 and S100A9 During the Inflammatory Response of Keratinocytes.
    Christmann C; Zenker S; Martens L; Hübner J; Loser K; Vogl T; Roth J
    Front Immunol; 2020; 11():599947. PubMed ID: 33643287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD100-Plexin-B2 Promotes the Inflammation in Psoriasis by Activating NF-κB and the Inflammasome in Keratinocytes.
    Zhang C; Xiao C; Dang E; Cao J; Zhu Z; Fu M; Yao X; Liu Y; Jin B; Wang G; Li W
    J Invest Dermatol; 2018 Feb; 138(2):375-383. PubMed ID: 28927892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-17A plays a central role in the expression of psoriasis signature genes through the induction of IκB-ζ in keratinocytes.
    Muromoto R; Hirao T; Tawa K; Hirashima K; Kon S; Kitai Y; Matsuda T
    Int Immunol; 2016 Sep; 28(9):443-52. PubMed ID: 26944069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyr61/CCN1 is involved in the pathogenesis of psoriasis vulgaris via promoting IL-8 production by keratinocytes in a JNK/NF-κB pathway.
    Wu P; Ma G; Zhu X; Gu T; Zhang J; Sun Y; Xu H; Huo R; Wang B; Shen B; Chen X; Li N
    Clin Immunol; 2017 Jan; 174():53-62. PubMed ID: 27856305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.